001     164181
005     20240313115345.0
024 7 _ |a pmc:PMC9411893
|2 pmc
024 7 _ |a 10.1136/jmedgenet-2021-107965
|2 doi
024 7 _ |a pmid:34544842
|2 pmid
024 7 _ |a 0022-2593
|2 ISSN
024 7 _ |a 1468-6244
|2 ISSN
024 7 _ |a altmetric:113813568
|2 altmetric
037 _ _ |a DZNE-2022-00837
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Chen, Yong-Ping
|b 0
245 _ _ |a Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population.
260 _ _ |a London
|c 2022
|b BMJ Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1661506957_605
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a CC BY-NC: https://creativecommons.org/licenses/by-nc/4.0/
520 _ _ |a A large number of new causative and risk genes for amyotrophic lateral sclerosis (ALS) have been identified mostly in patients of European ancestry. In contrast, we know relatively little regarding the genetics of ALS in other ethnic populations. This study aims to provide a comprehensive analysis of the genetics of ALS in an unprecedented large cohort of Chinese mainland population and correlate with the clinical features of rare variants carriers.A total of 1587 patients, including 64 familial ALS (FALS) and 1523 sporadic ALS (SALS), and 1866 in-house controls were analysed by whole-exome sequencing and/or testing for G4C2 repeats in C9orf72. Forty-one ALS-associated genes were analysed.155 patients, including 26 (40.6%) FALS and 129 (8.5%) SALS, carrying rare pathogenic/likely pathogenic (P/LP) variants of ALS causative genes were identified. SOD1 was the most common mutated gene, followed by C9orf72, FUS, NEK1, TARDBP and TBK1. By burden analysis, rare variants in SOD1, FUS and TARDBP contributed to the collective risk for ALS (p<2.5e-6) at the gene level, but at the allelic level TARDBP p.Gly294Val and FUS p.Arg521Cys and p.Arg521His were the most important single variants causing ALS. Clinically, P/LP variants in TARDBP and C9orf72 were associated with poor prognosis, in FUS linked with younger age of onset, and C9orf72 repeats tended to affect cognition.Our data provide essential information for understanding the genetic and clinical features of ALS in China and for optimal design of genetic testing and evaluation of disease prognosis.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a genetic variation
|2 Other
650 _ 7 |a genetics
|2 Other
650 _ 7 |a medical
|2 Other
650 _ 7 |a neurodegenerative diseases
|2 Other
650 _ 2 |a Amyotrophic Lateral Sclerosis: epidemiology
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: genetics
|2 MeSH
650 _ 2 |a C9orf72 Protein: genetics
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Mutation: genetics
|2 MeSH
650 _ 2 |a Superoxide Dismutase-1: genetics
|2 MeSH
700 1 _ |a Yu, Shi-Hui
|b 1
700 1 _ |a Wei, Qian-Qian
|b 2
700 1 _ |a Cao, Bei
|b 3
700 1 _ |a Gu, Xiao-Jing
|b 4
700 1 _ |a Chen, Xue-Ping
|b 5
700 1 _ |a Song, Wei
|b 6
700 1 _ |a Zhao, Bi
|b 7
700 1 _ |a Wu, Ying
|b 8
700 1 _ |a Sun, Ming-Ming
|b 9
700 1 _ |a Liu, Fei-Fei
|b 10
700 1 _ |a Hou, Yan-Bing
|b 11
700 1 _ |a Ou, Ru-Wei
|b 12
700 1 _ |a Zhang, Ling-Yu
|b 13
700 1 _ |a Liu, Kun-Cheng
|b 14
700 1 _ |a Lin, Jun-Yu
|b 15
700 1 _ |a Xu, Xin-Ran
|b 16
700 1 _ |a Li, Chun-Yu
|b 17
700 1 _ |a Yang, Jing
|b 18
700 1 _ |a Jiang, Zheng
|b 19
700 1 _ |a Liu, Jiao
|b 20
700 1 _ |a Cheng, Yang-Fan
|b 21
700 1 _ |a Xiao, Yi
|b 22
700 1 _ |a Chen, Ke
|b 23
700 1 _ |a Feng, Fei
|b 24
700 1 _ |a Cai, Ying-Ying
|b 25
700 1 _ |a Li, Shi-Rong
|b 26
700 1 _ |a Hu, Tao
|b 27
700 1 _ |a Yuan, Xiao-Qin
|b 28
700 1 _ |a Guo, Xiao-Yan
|b 29
700 1 _ |a Liu, Hui
|0 P:(DE-2719)9001971
|b 30
|u dzne
700 1 _ |a Han, Qing
|b 31
700 1 _ |a Zhou, Qing-Qing
|b 32
700 1 _ |a Shao, Na
|b 33
700 1 _ |a Li, Jian-Peng
|b 34
700 1 _ |a Pan, Ping-Lei
|b 35
700 1 _ |a Ma, Sha
|b 36
700 1 _ |a Shang, Hui-Fang
|0 0000-0003-0947-1151
|b 37
773 _ _ |a 10.1136/jmedgenet-2021-107965
|g p. jmedgenet-2021-107965 -
|0 PERI:(DE-600)2009590-9
|n 9
|p 840-849
|t Journal of medical genetics
|v 59
|y 2022
|x 0022-2593
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/164181/files/DZNE-2022-00837.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/164181/files/DZNE-2022-00837.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:164181
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 30
|6 P:(DE-2719)9001971
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-28
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED GENET : 2021
|d 2022-11-17
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-17
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J MED GENET : 2021
|d 2022-11-17
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2022-11-17
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-17
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210000
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21